Literature DB >> 1480502

Pharmacodynamic factors of antibiotic efficacy.

J C Rotschafer1, R A Zabinski, K J Walker.   

Abstract

The primary focus of the pharmaceutical industry in past years has been on developing more potent antibiotics rather than on establishing optimum therapy with currently available agents. Concepts that can be used to tailor patient- and pathogen-specific antimicrobial regimens include concentration-dependent killing, concentration-independent killing, and postantibiotic effect. It is possible to administer single daily doses (SDD) of aminoglycosides; however, a fixed SDD regimen cannot meet the goals for therapy in all patients. Instead, it is necessary to consider both pharmacodynamic concepts and pharmacokinetic principles. Even with tailored, patient-specific regimens, however, limitations exist with antibiotic therapy alone. Immunotherapy, used as an adjunct to antimicrobial therapy, may play a role in improving patient outcomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1480502

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

Review 1.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

2.  Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model.

Authors:  S Corvaisier; P H Maire; M Y Bouvier d'Yvoire; X Barbaut; N Bleyzac; R W Jelliffe
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 3.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.

Authors:  Joseph L Kuti; Blair Capitano; David P Nicolau
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 5.  The glycylcyclines: a comparative review with the tetracyclines.

Authors:  George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern Vercaigne; John Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Estimating amoxicillin influx/efflux in chinchilla middle ear fluid and simultaneous measurement of antibacterial effect.

Authors:  Yue Huang; Zheng Yang; Linda Cartier; Belinda Cheung; Ronald J Sawchuk
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

7.  Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.

Authors:  J A Karlowsky; G G Zhanel; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 8.  A practical guide to the diagnosis, treatment, and prevention of neonatal infections.

Authors:  Roberto Parulan Santos; Debra Tristram
Journal:  Pediatr Clin North Am       Date:  2015-04       Impact factor: 3.278

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.